Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 10/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.62 |
| ▸ | MAPT | P10636 | 7/20 | 0.62 |
| ▸ | GAA | P10253 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 5/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20796131 | 0.86 | MEN1 (0.74) | MEN1KMT2AMAPTGAALMNA | |
| SCHEMBL8503181 | 0.82 | KMT2A (0.60) | MEN1KMT2AMAPTGAALMNA | |
| SCHEMBL8503182 | 0.82 | KMT2A (0.60) | MEN1KMT2AMAPTGAALMNA | |
| SCHEMBL31503950 | 0.82 | KMT2A (0.60) | MEN1KMT2AMAPTGAALMNA | |
| SCHEMBL930847 | 0.82 | GAA (0.65) | MEN1KMT2AMAPTGAALMNA | |
| SCHEMBL1446574 | 0.82 | KMT2A (0.60) | MEN1KMT2AMAPTGAALMNA | |
| SCHEMBL5528679 | 0.82 | GAA (0.65) | MEN1KMT2AMAPTGAALMNA | |
| SCHEMBL18469873 | 0.82 | KMT2A (0.60) | MEN1KMT2AMAPTGAALMNA | |
| Hydrochloric Acid SCHEMBL3117154 | 0.81 | KMT2A (0.58) | MEN1KMT2AMAPTGAALMNA | |
| SCHEMBL28217933 | 0.79 | KMT2A (0.57) | MEN1KMT2AMAPTGAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0596491-B1 | Method for halogenating an aromatic compound | ISHIHARA SANGYO KAISHA (JP) | 1996-07-10 | — | — | EP | claimed |
| US-5491239-A | Method for halogenating an aromatic compound | ISHIHARA SANGYO KAISHA LTD. (JP) | 1996-02-13 | — | — | US | claimed |
| EP-0596491-A1 | Method for halogenating an aromatic compound | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1994-05-11 | — | — | EP | claimed |
| EP-1831198-B1 | PYRIDINE CARBOXAMIDE DERIVATIVES FOR USE AS ANTICANCER AGENTS | ASTRAZENECA AB (SE) | 2009-04-08 | — | — | EP | disclosed |
| EP-1831198-A1 | PYRIDINE CARBOXAMIDE DERIVATIVES FOR USE AS ANTICANCER AGENTS | AstraZeneca AB (SE) | 2007-09-12 | — | — | EP | disclosed |
| WO-2006067446-A1 | PYRIDINE CARBOXAMIDE DERIVATIVES FOR USE AS ANTICANCER AGENTS | ASTRAZENECA AB (SE) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006067445-A2 | CSF-1R KINASE INHIBITORS | ASTRAZENECA AB (SE) | 2006-06-29 | — | — | WO | disclosed |
| EP-0596491-B1 | Method for halogenating an aromatic compound | ISHIHARA SANGYO KAISHA (JP) | 1996-07-10 | — | — | EP | disclosed |
| US-5491239-A | Method for halogenating an aromatic compound | ISHIHARA SANGYO KAISHA LTD. (JP) | 1996-02-13 | — | — | US | disclosed |
| EP-0596491-A1 | Method for halogenating an aromatic compound | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1994-05-11 | — | — | EP | disclosed |